The effect of Sulindac on proliferation and β-catenin protein expression of human liver cancer cell HepG2

Chinese Journal of Clinical Anatomy ›› 2015, Vol. 33 ›› Issue (4) : 447-450.

Chinese Journal of Clinical Anatomy ›› 2015, Vol. 33 ›› Issue (4) : 447-450. DOI: 10.13418/j.issn.1001-165x.2015.04.016

The effect of Sulindac on proliferation and β-catenin protein expression of human liver cancer cell HepG2

  • DENG Xiao-hui,ZHANG Ying-hua,FANG Fang,SONG Hai-yan,FU Sheng-qi
Author information +
History +

Abstract

Objective To observe the effect of Sulindac on proliferation, apoptosis of human liver cancer cell HepG2 and the expression of β-catenin protein, and to investigate the possible anti-cancer mechanism of Sulindac. Methods HepG2 cells were treated with different dose of Sulindac. The inhibitory effect of Sulindac on proliferation was detected by MTT assay. Hoechst 33258 staining was applied to analyze the effect of Sulindac on apoptosis of HepG2 cell. The expression ofβ-catenin protein in the Wnt pathway was detected by RT-PCR and Western blotting. Results Sulindac could inhibit the proliferation of liver cancer cell HepG2 with time and dose dependence. The number of apoptotic cells after treated with Sulindac for 24h was larger than those treated with DMSO. The expression of β-catenin appeared to decrease with the increase of drug concentration.  Conclusion Sulindac can inhibit the growth of liver cancer HepG2 cells. It can block the Wnt signal transduction pathway, and reduce the expression ofβ-catenin, which may be the mechanism of its anti-tumor effect.

Key words

 Sulindac / Hepatocellular carcinoma / Apoptosis

Cite this article

Download Citations
The effect of Sulindac on proliferation and β-catenin protein expression of human liver cancer cell HepG2[J]. Chinese Journal of Clinical Anatomy. 2015, 33(4): 447-450 https://doi.org/10.13418/j.issn.1001-165x.2015.04.016

References

[1] Hu D, Fang W, Han A, et al. c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt/beta-catenin signaling through GSK3beta pathway[J]. Carcinogenesis, 2008, 29(12):2317-2324.
[2]  赵霞, 李乐, 赵玉元. 舒林酸抑制肝癌HepG_2细胞增殖的实验研究[J]. 中华肿瘤防治杂志, 2006,13(4):271-274.
[3]  黄伟平, 黄月红, 陈治新, 等. 舒林酸对HBV X基因转染的肝癌细胞Wnt信号通路的影响[J]. 胃肠病学和肝病学杂志, 2010,19(8):703-707.
[4]  Gao W, Kim H, Feng M, et al. Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy[J]. Hepatology, 2014, 60(2):576-87.
[5]  邵娟, 辛晓燕, 段海霞, 等. 舒林酸对卵巢癌细胞株A2780、SKOV3的凋亡作用[J]. 肿瘤防治研究, 2011, 38(8):971.
[6]  孙海涛, 贺松其, 文彬, 等. 鳖甲煎丸对肝癌细胞中Wnt信号分子β-catenin、GSK-3β及靶基因CD44v6、VEGF的影响[J]. 南方医科大学学报, 2014,34(10):1454-1458.
[7]  刘志龙, 曹明溶, 李强, 等. 青蒿琥酯对人肝癌HepG2细胞增殖和凋亡的影响及联合化疗药物的抗肝癌效应[J]. 中国病理生理杂志, 2012, 28(2):287-291.
[8]  邵军良, 韩明芳, 黎运呈. 桂皮酸联合顺铂对人肝癌MHCC97细胞的增殖抑制和凋亡诱导作用[J]. 中国病理生理杂志, 2013, 29(7):1219-1224.
[9]  王玉, 叶建明. 经典Wnt信号通路在原发性肝癌发生中的作用[J]. 中华普通外科学文献(电子版), 2011, 5(1):50-53.

Accesses

Citation

Detail

Sections
Recommended

/